Therefore, we initially assessed the interaction between Notch and BCR-ABL in primary CD34+ CML cells and then proceeded to establish these interactions in CML cell line models. The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.